Icotrokinra Hydrochloride Patent Expiration
Icotrokinra Hydrochloride was first introduced by Janssen Biotech Inc
Icotrokinra Hydrochloride Patents
Given below is the list of patents protecting Icotrokinra Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Icotyde | US11939361 | Compositions Of Peptide Inhibitors Of Interleukin-23 Receptor | Nov 19, 2041 | Janssen Biotech |
| Icotyde | US11845808 | Peptide Inhibitors Of Interleukin-23 Receptor And Their Use To Treat Inflammatory Diseases | Jan 14, 2041 | Janssen Biotech |
| Icotyde | US12552836 | Jul 12, 2039 | Janssen Biotech |
Icotrokinra Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List